Back to Search
ALAN KOVAR, M.D.
M.D.
Anesthesiology Physician
NPI: 1629397500IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
94-07375(KS)MD170464(OR)
Critical Care Medicine (Anesthesiology) Physician
Anesthesiology — Critical Care Medicine
Code: 207LC0200X
MD170464(OR)123306(OH)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Class of 2010
Research & Publications (15)
Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma.
PMID 19640287·J Transl Med·2009
3-trial
Changes in blood pressure after administration of hydroxocobalamin: relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers.
PMID 18584369·Clin Toxicol (Phila)·2008
2-rct
Population pharmacokinetic data analysis of three phase I studies of matuzumab, a humanised anti-EGFR monoclonal antibody in clinical cancer development.
PMID 18319714·Br J Cancer·2008
8-other
Population pharmacokinetics of cetuximab in patients with squamous cell carcinoma of the head and neck.
PMID 18218786·J Clin Pharmacol·2008
8-other
Investigation of the impact of sarizotan on the pharmacokinetics of levodopa.
PMID 17654694·Biopharm Drug Dispos·2007
2-rct
Pharmacokinetics of sarizotan after oral administration of single and repeat doses in healthy subjects.
PMID 17542349·Int J Clin Pharmacol Ther·2007
2-rct
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.
PMID 17156477·BMC Cancer·2006
3-trial
Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study.
PMID 16990190·Clin Toxicol (Phila)·2006
2-rct
Investigation of sarizotan's impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial.
PMID 16525816·Eur J Clin Pharmacol·2006
2-rct
The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction.
PMID 16100293·J Clin Pharmacol·2005
4-observational
Pharmacokinetic profile of cetuximab (Erbitux) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma.
PMID 16051481·Eur J Cancer·2005
3-trial
Population pharmacokinetics of eniporide and its metabolite in healthy subjects and patients with acute myocardial infarction.
PMID 15901744·J Clin Pharmacol·2005
4-observational
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.
PMID 14701780·J Clin Oncol·2004
3-trial
Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx.
PMID 11459205·Cancer Chemother Pharmacol·2001
3-trial
Pharmacokinetic/pharmacodynamic evaluation of the NHE inhibitor eniporide.
PMID 11210393·J Clin Pharmacol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3181 SW SAM JACKSON PARK RD
PORTLAND, OR 97239 - Phone
- (503) 494-4910
Quick Facts
- NPI
- 1629397500
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 16
- Publications
- 15
Are you this provider?
Claim Your Profile